Global Breast Implants Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023
The breast implants treatment market is increasing at a significant CAGR due to increase in the female population. Rising prevalence of breast cancer cases, growing demand for cosmetic surgeries, and women with a high preference for improving aesthetic appeal might fuel the growth of the breast implants market over the forecast period. Moreover, an increase in the awareness about reconstructive breast surgeries, favorable demographics across the globe, and an increase in aging population are the key factors propelling the global breast implants market growth. However, increased risk of developing serious complications including deflation, capsular contracture, infection, and breast and nipple sensitivity, and high costs of the implant procedures are the major factors hampering the growth of the global breast implants market over the forecast period.
A sample of this report is available upon request @
The breast implants market is segmented on the basis of product type, application type, and end user
Based on product type, the breast implants market has been segmented into the following:
· Silicone breast implants
· Structured saline breast implants
· Saline breast implants
· Gummy bear breast implants
· Round breast implants
· Smooth breast implants
· Textured breast implants
Based on treatment type, the breast implants market has been segmented into the following:
· Reconstructive surgery
· Cosmetic surgery
Based on the end user, the breast implants market has been segmented into the following:
· Hospitals
· Cosmetology clinics
· Ambulatory surgical centres
To view TOC of this report is available upon request @
Global breast implants market is in growing stage with the innovation of novel implants into the breast implants market. Increase in the prevalence of breast cancer cases, (according to World Health Organization every year around 200,000 new cases in women), growing preference for enhancing physical appearance might fuel the breast implants market. According to American Society of Plastic Surgeons (ASPS), breast augmentation surgeries were increased about 31% from 2000 to 2015. Launching of new products, innovation of less invasive surgical procedures, and product approvals from various regulatory bodies such as U.S. Food and Drug Administration might boost the breast implants market over the forecast period. For instance, in February 2013, FDA approved a silicone gel-filled breast implant manufactured by Allergan Plc, which uses more cohesive silicone gel, compared with previously approved breast implants. Similarly, In June 2013, the U.S. FDA has approved a silicone gel-filled breast implant which uses a more cohesive silicone gel manufactured by Mentor’s PMA, compared with their previously approved breast implants. Moreover, acquisitions and mergers, collaborations, and key licensing agreements also bolster the breast implants market growth. For instance, in December 2008, Johnson & Johnson has acquired breast-implant maker Mentor Corporation for the manufacturing of breast implants. In March 2015, Actavis plc has acquired of Allergan, Inc. to manufacture breast implants.
Need more information about this report @
Some of the players in the breast implants market are Allergan (U.S.), GC. Aesthetics (Ireland), Groupe Seb (France), Johnson & Johnson Services Inc.,(U.S.), Sientra, Inc. (U.S.), Polytech Health & Aesthetics GmbH (Germany), Establishment Labs S.A. (Costa Rica), Shanghai Kangning Medical Supplies Ltd. (China), Guangzhou Wanhe Plastic Materials Co., Ltd. (China), Laboratoires Arion (France), and Hansbiomed Co. Ltd (Korea).
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.
Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @https://www.precisionbusinessinsights.com
FDA Approves Aurinia Pharmaceuticals' (Nasdaq: AUPH / TSX: AUP) LUPKYNIS (voclosporin) for Adult Patients with Active Lupus Nephritis
